Periodontal Disease Treatment Market

The report "Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs), and Region - Global Forecast to 2031" is projected to reach USD 3.86 billion by 2031 from USD 2.86 billion in 2026, at a CAGR of 6.2% during the forecast period.

Browse 250 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on "Periodontal Disease Treatment Market, by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs), and Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/periodontal-disease-treatment-market-84851649.html

The market for periodontal disease treatment is mainly expanding as more people worldwide suffer from periodontal diseases due to bad oral hygiene, smoking, diabetes, and an increase in the elderly population. The number of people who are becoming aware of oral health and its impact on the overall health system has led to more patient visits for preventive and therapeutic treatments. Achievements in dental technology, such as the use of advanced surgical instruments that cause less trauma, laser therapies, and digitally integrated diagnostic tools, have not only made treatments more efficient but also brought clinical outcomes to a level that has convinced more dental practitioners to use these tools. Besides that, market growth is being facilitated by an upsurge in the number of dental clinics, higher disposable incomes, and an increased focus on preventive dental care, which in turn has resulted in greater demand for both non-surgical and surgical periodontal treatments.

Non-surgical treatment accounted for the largest share, by treatment type, in 2025.

In the treatment type segment, the largest market share is held by non-surgical treatments, mainly because of their widespread adoption as the primary mode of treatment for the disease, especially for conditions such as gingivitis and stage I periodontitis. This is mainly because of the efficiency as well as the cost-effectiveness of the treatment process, as well as its ability to handle the disease effectively. This process does not require a highly sophisticated infrastructure, mainly because of the relatively less invasive nature of the treatment process, especially when done in the dental setting.

The hospitals segment accounted for the largest share of the periodontal disease treatment market, by end user, in 2025.

In the end-user market, hospitals hold the largest market share. This is because they can provide overall dental and periodontal care to patients. Hospitals have advanced diagnostic imaging facilities and dental surgeons who can provide treatment for periodontal diseases. They also have the capability to treat patients in larger volumes because they have the capability to treat patients who have severe periodontal diseases or patients who have various other health-related problems that need overall treatment. Due to these factors, it can be concluded that hospitals have the largest share in the market for the treatment of periodontal diseases.

Key Market Players

The key players in the periodontal disease treatment market are Dentsply Sirona (US), Henry Schein, Inc. (US), Nakanishi Inc. (Japan), Yoshida Dental MFG. Co., Ltd. (Japan), Institut Straumann Holdings AG (Switzerland), Envista Holdings Corporation (US), BIOLASE, Inc. (US), and other players.

Don’t miss out on business opportunities in Keyword. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/